SCHEMBL8590983

SCHEMBL8590983

O=C1Nc2ccccc2NC2=C1CC=C2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACVR1 Q04771 3/20 0.44
LRRK2 Q5S007 3/20 0.44
PDGFRA P16234 2/20 0.44
FER P16591 2/20 0.44
LTK P29376 2/20 0.44
DYRK1B Q9Y463 2/20 0.44
CDK8 P49336 1/20 0.44
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
CDK5 Q00535 5/20 0.36
ROS1 P08922 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CYP1A2 P05177 1/20 0.36
GSK3A P49840 4/20 0.35
GSK3B P49841 4/20 0.35
PLK4 O00444 3/20 0.35
AURKA O14965 3/20 0.35
CHEK2 O96017 3/20 0.35
CDK2 P24941 3/20 0.35
CSNK1D P48730 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11168286 0.81 ACVR1 (0.41) ACVR1LRRK2PDGFRAFERLTK
SCHEMBL5697347 0.76 ACVR1 (0.67) ACVR1LRRK2PDGFRAFERLTK
SCHEMBL28517190 0.73 PDGFRA (0.35) ACVR1LRRK2PDGFRAFERLTK
SCHEMBL4490831 0.72 LRRK2 (0.51) ACVR1LRRK2PDGFRAFERLTK
SCHEMBL28552531 0.72 AHR (0.50) CDK5CYP1A2AHRPDK2BRD4
SCHEMBL29591948 0.67 MAPT (0.52) SMN1; SMN2AHRPDK2BRD4CREBBP
SCHEMBL1247901 0.67 MAPT (0.52) SMN1; SMN2AHRPDK2BRD4CREBBP
SCHEMBL18677464 0.67 ACVR1 (0.45) ACVR1LRRK2PDGFRAFERLTK
SCHEMBL8201662 0.66 BRD4 (0.43) SMN1; SMN2BRD4CREBBPMEN1KMT2A
SCHEMBL18944286 0.65 BRD4 (0.41) ACVR1LRRK2PDGFRAFERLTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0828731-A1 TRICYCLIC DIAZEPINES USEFUL AS GnRH RECEPTOR ANTAGONISTS Takeda Chemical Industries, Ltd. (JP) 1998-03-18 EP disclosed